Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial

NCT05882305 is registered in ClinicalTrials.gov with Kousai Bio Co., Ltd. as lead sponsor.

NCT NCT05882305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05882305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KSD-101 Therapy for EBV-associated Lymphomas: an Exploratory Clinical Trial
Lead sponsor
Kousai Bio Co., Ltd.
Phase
Phase 1
Overall status
Withdrawn
Start date
June 10, 2023
Completion date
December 31, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ebv-associated lymphomas